Adjusted hazard ratios and 95% Cls for Fuchs Endothelial Corneal Dystrophy among those receiving conjugated equine estrogen alone or conjugated equine estrogen plus Medroxy Progesterone Acetate compared with placebo with variables like age, race, BMI and smoking.
Randomized hormone therapy was not associated with incident Fuchs endothelial corneal dystrophy in postmenopausal women, indicating no effect on disease risk. #CornealDisease ja.ma/4tF9suA